Related Experiment Videos
Problems with resistance in pediatric intensive care
1Division of Pediatric Pharmacology, Rainbow Babies and Childrens Hospital, Cleveland OH 44106, USA.
Insights
Antibiotic resistance in neonatal and pediatric intensive care units (ICUs) requires investigation. Emerging resistant Gram-negative bacteria in PICUs may be community-acquired, necessitating reassessment of control strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pediatric Critical Care
Background:
- Antibiotic resistance epidemiology in neonatal and pediatric intensive care units (ICUs) is understudied.
- Patient factors (health status, immune maturity, prior antibiotic exposure) may alter resistance patterns compared to adults.
- Key concerns include methicillin-resistant Staphylococcus aureus (MRSA) in neonatal ICUs and antibiotic-resistant Gram-negative bacteria in pediatric ICUs (PICUs).
Purpose of the Study:
- To investigate the unique aspects of antibiotic resistance in neonatal and pediatric intensive care environments.
- To examine the origins and transmission dynamics of resistant pathogens in these vulnerable patient populations.
- To evaluate the effectiveness of current infection control and antibiotic stewardship strategies.
Main Methods:
- Review of existing literature on antibiotic resistance in neonatal and pediatric ICUs.
- Analysis of epidemiological data concerning resistant pathogens.
- Assessment of infection control challenges, including personnel colonization and transmission.
- Evaluation of the impact of antibiotic restriction policies.
Main Results:
- Methicillin-resistant Staphylococcus aureus (MRSA) outbreaks in neonatal ICUs present significant infection control challenges, particularly concerning nursery personnel.
- Emergence of antibiotic-resistant Gram-negative bacteria in PICUs is a growing concern.
- Evidence suggests these Gram-negative pathogens are often imported from the community, not solely due to internal antibiotic practices.
Conclusions:
- The distinct patient populations in neonatal and pediatric ICUs may lead to different antibiotic resistance profiles compared to adult settings.
- Current infection control strategies for MRSA in neonatal ICUs need to address personnel colonization.
- The community origin of resistant Gram-negative bacteria in PICUs challenges the efficacy of internal antibiotic restriction policies and necessitates revised control strategies.
Abstract:
Antibiotic resistance in the neonatal and pediatric intensive care environments has not been rigorously investigated. There is reason to believe that the epidemiology of antibiotic resistance in these settings may be different from that in other hospital settings because the patients' preadmission health status, the maturity of their immune systems, and their outpatient exposure to antibiotics are different from those seen in adults. At the present time, the areas of greatest concern are the outbreaks of infection caused by methicillin-resistant Staphylococcus aureus in the neonatal ICUs and the emergence of antibiotic-resistant Gram-negative bacteria in pediatric intensive care units (PICU). In the former, colonization and transmission by nursery personnel remains one of the great challenges in infection control. In the latter, new information is emerging which challenges the notion that antibiotic-restriction policies might be an effective means for modulating the emergence of antibiotic-resistant Gram-negative pathogens in the pediatric intensive care environment. It appears that these organisms are largely imported into the ICU from the community and are not a result of antibiotic practices within the unit itself. This observation requires that strategies to control these organisms in the PICU be reassessed.